• Smurf1 Downregulation Enhances Cisplatin Sensitivity in CRC

  2026-06-26

  This study demonstrates that low Smurf1 expression significantly increases the chemosensitivity of human colorectal cancer (CRC) to cisplatin and gemcitabine in both in vitro and patient-derived xenograft models. The findings highlight Smurf1 as a potential biomarker and therapeutic target to improve the efficacy of platinum-based chemotherapy in CRC.

• Technical Guidance: Angiotensin I/II (1-5) in RAS Workflows

  2026-06-26

  Angiotensin I/II (1-5) (Asp-Arg-Val-Tyr-Ile peptide) enables precise modeling of the renin-angiotensin system in cardiovascular and renal research, particularly for blood pressure regulation and aldosterone signaling studies. This product should not be used in unrelated peptide signaling research due to its narrow biochemical specificity and solubility profile.

• Dasatinib Monohydrate in Tumor Assembloid & Leukemia Workflo

  2026-06-25

  Dasatinib Monohydrate (BMS-354825) is redefining kinase inhibition, enabling precise targeting in both imatinib-resistant leukemia and complex assembloid cancer models. This article delivers actionable protocols, troubleshooting insights, and an evidence-based bridge from bench to translational research for scientists seeking robust, physiologically relevant results.

• Alda 1: Potent ALDH2 Activator for Cardiac and Radiation Res

  2026-06-25

  Alda 1 is a well-characterized ALDH2 activator that significantly enhances enzymatic activity in wild-type and ALDH2*2 variants. It demonstrates robust cardioprotection in ischemia models and mitigates radiation-induced dermatitis, supporting its research utility. All claims are substantiated by peer-reviewed and manufacturer data.

• ICG001: Precision Wnt/β-Catenin Pathway Inhibitor in Disease

  2026-06-24

  ICG001 stands out as a selective Wnt/β-catenin pathway inhibitor, enabling researchers to dissect CBP/β-catenin interactions in cancer, fibrosis, and regenerative applications. This article offers stepwise protocols, troubleshooting strategies, and comparative insights to maximize experimental success with ICG001 in complex cellular and animal models.

• SB-505124 Hydrochloride: Transforming Fibrosis and Cancer Re

  2026-06-23

  This thought-leadership article explores the mechanistic foundation and translational potential of SB-505124 hydrochloride as a selective TGF-β/activin pathway inhibitor. Drawing on recent mechanobiology insights and validated experimental protocols, we provide strategic guidance for researchers aiming to bridge fundamental discoveries with impactful preclinical outcomes.

• Amyloid Beta-Peptide (1-40) (human): Applied Alzheimer’s Res

  2026-06-23

  Amyloid Beta-Peptide (1-40) (human) enables cutting-edge modeling of amyloid aggregation, neurotoxicity, and neuroimmune regulation in Alzheimer’s research. This article delivers actionable workflows and troubleshooting insights, uniquely integrating the latest evidence on microglial modulation for reproducible, discovery-focused experimentation.

• Applied Membrane Protein Purification with n-Dodecyl-β-D-mal

  2026-06-22

  n-Dodecyl-β-D-maltoside (DDM) is a gold-standard non-ionic detergent for solubilizing, stabilizing, and analyzing membrane proteins without compromising structure or function. Explore how DDM, supplied by APExBIO, enables high-fidelity workflows in integrin cryo-EM studies and beyond, with actionable troubleshooting and optimization strategies.

• PtrbZIP12 Directly Regulates Drought Response via PtrDHN and

  2026-06-22

  This study demonstrates that the bZIP transcription factor PtrbZIP12 enhances drought resistance in Populus trichocarpa by directly activating the stress-related genes PtrDHN and PtrPOD. The research highlights the importance of phosphorylation in modulating this transcriptional response, providing a mechanistic framework for understanding post-translational regulation under drought stress.

• Tigecycline in Multidrug-Resistant Bacteria Assays: Workflow

  2026-06-21

  Tigecycline, a pioneering glycylcycline antibiotic, empowers robust workflows for multidrug-resistant (MDR) bacterial research with proven efficacy and reliability. This article translates the latest reference findings into actionable protocols, troubleshooting strategies, and comparative insights for researchers tackling complicated infections and resistance challenges.

• 5-(N,N-dimethyl)-Amiloride Hydrochloride: New Horizons in En

  2026-06-20

  Explore the advanced role of 5-(N,N-dimethyl)-Amiloride hydrochloride in dissecting endothelial injury mechanisms during sepsis. This in-depth analysis integrates cutting-edge biomarker insights, surpassing standard reviews to guide innovative assay design.

• seRNA-NPCm Drives Nasopharyngeal Carcinoma Metastasis via ND

  2026-06-19

  This study reveals how the carcinogen N,N’-Dinitrosopiperazine induces a super-enhancer RNA (seRNA-NPCm) that promotes metastasis in nasopharyngeal carcinoma through the NPM1/c-Myc/NDRG1 signaling pathway. The findings highlight a mechanistic link between environmental carcinogens, enhancer RNA biology, and metastatic gene regulation, offering new insights for biomarker and therapeutic research.

• Plk1-Mediated Regulation of p31comet in Mitotic Checkpoint D

  2026-06-19

  This study uncovers how Polo-like kinase 1 (Plk1) phosphorylates and modulates p31comet, directly regulating the disassembly of mitotic checkpoint complexes and ensuring accurate chromosome segregation. These insights clarify a key control mechanism in cell cycle progression, with implications for both basic research and translational studies on checkpoint fidelity.

• Honokiol: Precision NF-κB Inhibition and Antioxidant Workflo

  2026-06-18

  Honokiol unlocks reproducible, high-fidelity modulation of inflammatory and angiogenic signaling in cancer and immunometabolic research. This article details advanced experimental workflows, actionable troubleshooting, and the integration of fractional viability metrics for next-generation in vitro drug assessment.

• Sulfo-NHS-SS-Biotin: Precision Tools for Dynamic Surface Pro

  2026-06-18

  This thought-leadership article examines how Sulfo-NHS-SS-Biotin empowers translational researchers to interrogate cell surface proteomes with mechanistic precision. Drawing on new insights from retinal neurodegeneration studies and integrating best practices for affinity purification, we position this cleavable biotin disulfide N-hydroxysulfosuccinimide ester as a next-generation platform for dynamic protein labeling and reversible enrichment. The discussion spans mechanistic rationale, experimental validation, and strategic guidance—escalating beyond standard product summaries to contextualize APExBIO’s Sulfo-NHS-SS-Biotin within the evolving landscape of translational proteomics.

462 records 14/31 page Previous Next First page 上5页 1112131415 下5页 Last page